‹ go back

23rd August 2018 –SENSIUM recently asked to join a consortium that intends to improve the care provided to heart failure patients by monitoring them more closely in their own homes.

The program is revolutionary, as it involves patients being admitted to the hospital but never actually attending the hospital site.  All care is provided in the patient’s home by clinicians working outside of their hospital and this type of initiative is expected to become more commonplace as healthcare demand reaches unprecedented levels.   


The program is being funded by the European Union through the Interreg North West Europe Programme. This programme is intended to foster close international cooperation to make North-Western Europe a key economic player and an attractive place to work and live, with high levels of innovation, sustainability and cohesion. The grant title is “NWE-Chance”; it involves the development and validation of promising integrated eHealth applications combined with nanotechnology for hospitalisation of heart failure patients at home, and will run over 3 years from May 2018 – May 2021. The total grant funding awarded was 1.98M euros, with SENSIUM securing 420K euros of the available budget.


Dr Alison Burdett, SENSIUM Chief Scientific Officer leading the SENSIUM element of the project had this to say:


“We are delighted to have been asked to participate in this very novel approach to delivering patient care. It really is an endorsement of our how robust our technology is that we were selected ahead of other providers as the preferred partner for this program.


This award will really help with our product enhancement activities as most of the product development effort required to satisfy this grant had already been identified as priority areas for SENSIUM in the next few years. The security that this grand funding now provides means that we can significantly accelerate our development into monitoring outside of a typical hospital environment.


This project will also allow us to get early clinical and new patient pathway feedback, as the final phase will see the new system being deployed in patients’ homes. Working with innovative leaders such as the Isala Clinic will mean that we can take this early experience and use it to help other forward-thinking hospitals to develop similar pathways, with the Sensium system as the key enabler.”


The development areas for the Sensium system will see a new simple plug and play Home Bridge being designed and developed from scratch. Other developments will include the transmission of a single lead ECG trace and the inclusion of an accelerometer to monitor the patient’s activity level.    


SENSIUM’s partners in the program include:

Isala Clinic (Netherlands), Jessa Ziekenhuis (Belgium), HC@Home (Netherlands), CE-Mate (Netherlands), European Health Telematics Association (Belgium), Universiteit Hasselt (Belgium), Digital Health and Care Institute (University of Strathclyde, UK), Klinikum der Stadt Ludwigshafen am Rhein (Germany), Build in Europe (Belgium)




‹ go back